3^rd Asia Pacific Oncology and Cancer Conference July 28-29, 2021 Tokyo, Japan

Track 1: Fields of Oncology

Oncology/Cancer is the branch of medicine that researches, identifies and treats cancer. A physician works in the field of oncology/Cancer is an oncologist.

Oncologists must first diagnose cancer, which is usually carried out via biopsy, endoscopy, X-ray, CT scanning, MRI, PET scanning, ultrasound or other radiologicalical methods. Nuclear medicine techniques can also be used to diagnose cancer as can blood tests or tumor markers. Oncology is often linked with haematology oncology, which is the branch of medicine that deals with blood and blood-related disorders.

Track 2: Types of Oncology

Oncology is the study of tumor or cancer. Most of the tumors are not cancerous. The cancerous tumors are called malignant tumors. Commonly oncology implies the study of malignant tumors or cancer. The doctor who practices oncology is an oncologist. There are different kinds of oncologists. Those who practiced in surgery are called surgical oncologists. Those who practiced in radiation therapy are called radiation oncologists. Those who practiced in the care of persons with cancer and administer chemotherapy are medical oncologists.

Track 3: Solid tumor

An abnormal mass of tissue and cells that generally does not contain cysts or liquid areas. Solid tumors may be benign Tumors (not cancer), or malignant (cancer). Different categories of solid tumors are named for the type of cells. Some of the examples of solid tumors are sarcomas, carcinomas, and lymphomas. Leukemias (cancers of the blood) usually do not form solid tumors.

One common carcinoma is adrenocortical carcinoma. This is when a tumor progresses in one or both adrenal glands, located above each kidney.

Track 4: Neurosurgical Oncology

Neurosurgical Oncology is a complex surgical method that presupposes treatment, diagnosis, and rehabilitation of disorders affecting any region of the Nervous System. Some of the preponderance is common Neuro surgeries are skull base surgery, Image Guided Surgery, Laser Surgery, Spinal Neurosurgery and Neuro surgical treatment.

Track 5: Nursing Oncology

A Nursing Oncology will gives care to growth patients and those are in danger for getting the sickness. They screen physical conditions, recommend solution and oversee chemotherapy and many medications for cancer. Oncology and Cancer is a standout among the most crucial and remunerating fields in nursing. One of the crucial parts of the cancer nurture is quiet appraisal. They are in charge of surveying patients who have initiated because of treatment reactions, and also evaluating patients, amid and post-chemotherapy. The oncology nurture necessary to have the capacity to comprehend pathology comes about and their suggestions, and have an inside and out learning of the normal symptoms of growth medicines. The oncology nurture like to utilize her relational aptitudes to tune in to the patient, surveying their comprehension of the malady and its procedure and also the patient's passionate state.

Track 6: Medical & Radiation Oncology

Radiation Oncology enclosed all aspects of research that impacts the treatment of oncology using radiation. Radiotherapy can be given as a curative modality, either alone or in combination with surgery and/or chemotherapy. It may be used palliative, to relieve symptoms in patients with incurable cancers. Radiotherapy is expensively segmented into Radiotelegraphy, Brachy-radiotherapy and Metabolic Radiotherapy.

Track 7: Neuro Oncology

The Central Nervous System is denounced to various malevolent personality disorders. Central Nervous System covers its mechanism, Metastatic pestilence, Ramification, Cancers, Neurons and Sensory Receptors, Neurological Disorders, Multiple sclerosis and Imaging agents to CNS neurofibromatosis. Cancer spreads to the Nervous System by direct invasion or compression from continuous tissues relates to the proximity of the Nervous System to other structures. Central Nervous System Drugs market to grow at a CAGR of -3.2% over the period 2013-2018. The central nervous system (CNS) therapeutics peddle has been forecast to reach US$133 billion by the year 2018, which increases in disease ubiquity rates due to increase in population, introduction of new drugs, and increased outgo on healthcare.

Track 8: Brain Tumor

Brain Tumor develops when abnormal cells form inside the brain. The symptoms of Brain stem tumors vary greatly and can involve Ataxia, Cranial Nerve Palsy, headaches, problems with speech and swallowing, hearing loss, weakness, Hemiparesis, vision abnormalities, ptosis, and behavioural changes. Another possible symptom is vomiting. Any brain tumor is inherently serious and life-threatening because of its infiltrative character in the limited space of the Intracranial Cavity.

Track 9: Cancer Cell Biology and genetics

Due to Cancers millions of death occurring every year. The study of cancer biology is one of the largest areas of scientific interest. Cancer cells progress specific hallmarks through a series of mutations in both oncogenes and tumour-suppressor genes. There is no definitive cure for cancer, the most of the cancer treatments serve to prolong the lives of cancer sufferers.

Track 10: Cancer Biomarkers

A Cancer biomarker refers to a substance that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted a particular response of the body to the presence of cancer. Genetic, epigenetic, proteomic and imaging biomarkers can be utilized for cancer diagnosis, prognosis, and epidemiology. Ideally, likewise biomarkers can be assayed in non-invasively collected bio fluids like blood or serum.

Track 11: Cancer metabolomics

Cancer metabolomics research is being used to discover diagnostic cancer biomarkers in the clinic, to better understand its complex heterogeneous nature, to discover pathways involved in cancer that could be used for new targets and to monitor metabolic biomarkers during therapeutic intervention. Cancer metabolomics approaches may also provide clues to personalized cancer treatments by providing useful information to the clinician about the cancer patient’s response to medical interventions. The ultimate goal of most Cancer Metabolomics studies is to discover cancer-specific diagnostic, prognostic or predictive biomarkers for a patient.

Track 12: Organ-Defined Cancers

Cancer can occur anywhere in the body. The most common sites of cancer among men involve lung, prostate, colon, rectum, stomach, Brain and liver. Those for among women are breast, colon, rectum, lung, cervix, ovarian and stomach. Cancers are often described by the body part that originated in. Some body parts contain multiple types of tissue, so for greater precision, cancers can additionally be classified by the type of cell that the tumor cells originated from. The type of cancer a person has needed to be known properly as many types of cancer can behave very differently and respond to different treatments.

Track 13: Cancer: Psychological Aspects

If one is fighting cancer, it is common to experience psychological distress. Whether it is coping with the diagnosis, the challenges of treatment or continued worry about a recurrence, emotions brought on by the cancer experience can be crucial to handle.

Track 14: Lifestyle Changes to Improve Your Cancer Care

How we live can have pro­found effects on our health and wellness. This also applies for people who have cancer. A healthy lifestyle can support cancer treatments and help you to cure better. It may also improve your long-term health.

Track 15: Cancer Epigenetics and Oncogenomics

Cancer is a genetic disease affected by accumulation of DNA mutations and epigenetic alterations leading to unrestrained cell proliferation and neoplasm formation. The ambition of oncogenomics is to determined new oncogenes or tumor suppressor genes that may provide new insights into cancer diagnosis, predicting clinical outcome of cancers and new targets for cancer therapies. The success of targeted cancer therapies like Gleevec, Herceptin and a vastin raised the hope for oncogenomics to elucidate new targets for cancer treatment.

Track 16: Cancer Screening and Diagnostics

Cancer screening tests goal to find cancer early, before it causes symptoms and when it may be easier to treat successfully. Effective screening tests are those that:

• Reduce the chance that someone who screened regularly will die from cancer.
• Have more potential benefits than harms. (Possible harms of screening tests include bleeding or other physical damage, inaccurate test results, and overdiagnosis—the diagnosis of cancers that would not have caused problems and did not need treatment.)
• Diagnosing cancer at its earliest stages often provides the best chance for a cure.
• For few cancers, studies show screening tests can save lives by diagnosing cancer early. For other cancers, screening tests are recommended only for people with increased risk of their life.

Track 17: Cancer Vaccines

Cancer vaccines generally either treat existing cancer or prevent development of cancer. Cancer treatment vaccines are made up of cancer cells, parts of cells and pure antigens. Sometimes a patient’s own immune cells are removed and naked to these substances in the lab to create the vaccines.

Tracks 18: Clinical Trials in Cancer Treatment

Before any advance treatment is used with people in clinical trials, researchers work for many years to understand its effects on cancer cells in the lab and in animals. They also try to figure out the side effects it may cause.

Track 19: Innovations in Cancer Research and Oncology

Continuous Anticancer drug discovery and development is difficult to find a complete cure for cancer. Due to the drug resistance developed by tumor cells for existing treatments, this is becoming a mandatory approach to fight the disease.

• Scientific investigations on inhibitors of checkpoint CHK1 can be another milestone for anticancer drug discovery approach.
• Cancer cells are specifically dependent on molecular chaperones and related proteins that regulate homeostasis. These are promising targets for new anticancer therapies.

Deregulated apoptosis is hallmark of cancer and Bcl-2 family of proteins are pivotal to mediating the pathway of this process. Inhibiting their process can be a significant way for developing new anticancer drugs. Many plant sources are known to be important sources of novel anti-cancer properties.

Dear Colleagues,

Conference Series welcome you to the webinar 3^rd Asia Pacific Oncology and Cancer Conference during July 28-29, 2021 with a theme “Explore the Latest Innovative Treatment and Prevention of Oncology and Cancer Challenges”.

Cancer Summit 2021, webinar will focus on educational research directed toward its impact on clinical outcomes through oral and poster presentations, educational workshop sessions and influential plenary presentations. Cancer Summit 2021 is a perfect platform to find out how Cancer and Oncology research innovations helpful to the Medical, Health and human society. Cancer Summit 2021 will mainly focus on the trending topics during presentations of the two-day event, which reflect current education, research, developments and innovations internationally in the field of Cancer, Oncology and medical sectors. This includes prompt Keynote Presentations, Oral Talks, Poster Presentations, Video Presentations and Exhibitions.

Overview of Oncology and Cancer:

The Innovative idea of Cancer has started great many researches to be embraced by the labs around the world. An extraordinary number of researchers and scientists taking a shot at Caner research, till date, no significant solution for this is recorded. Global Cancer will also provide two days of discussions on techniques and systems identified with administration and quality change of Cancer and in addition to investigate the new thoughts and ideas on worldwide scale and the themes incorporate lung malignancy, bosom disease, bone tumor, leukemia, blood cancer, cervical tumor, colon-rectum disease, pediatric malignancy, surgical tumor, Prostate growth, thyroid malignancy.

Global market is segmented into Europe, North America, Latin America, Asia Pacific, Middle East and Africa. According to market study, Market Value for Oncology will be more than double to $ 623 Million by 2020. A major part of the research is going on the top Universities across the globe. So many companies are associated with various Cancer Screening and Diagnostics instruments and other therapeutics. Besides this various societies, associations and research centers are also associated in this research field.

Target Audience:

• Cancer Pharmaceutical Companies
• Research scholars
• Pathologist
• Students
• Diagnostics companies
• Medical Practitioners
• Industrial Researchers
• Academicians
• Directors, Head of Department
• Chemotherapists
• Research and Development Department.
• Business Delegates
• Medical Colleges
• Rehabilitation Specialists
• Genetic scientists
• Cancer Associations
• Diagnostic Laboratory Professionals
• Hospital presidents/CEOs/COOs/VPs/trustees
• Hospital c-suite executives (operations, development, finance)
• Oncology specialists (medical, radiation, and surgical)
• Oncology program and practice administrators, managers, and service line executives
• Healthcare consultants, vendors, and suppliers
• Cancer program marketing and public relations professionals
• Exhibitors and people with keen interest in the research areas of Cancer Research.

Who should sponsor/exhibit:

• Basic and Translational Laboratory Researchers       
• Hospitals
• Educational Institutes
• Research Centers
• Charitable Foundations focused on funding research, advocating for and supporting the needs

Why to attend?

Oncology and Cancer will enlighten the people with the most recent advancements in Cancer diagnosis, Cancer Science, Cancer therapy, Cancer treatment etc., around the world and to glow the related research ideas regarding Cancer Research & Oncology.

The aim of the webinar is to provide a platform to academicians and practitioners from multiple disciplines to debate and deliberate on social change that is encompassed by innovation and technology.

 Benefits of Attending the Webinar:

• Networking Opportunities, Grow Your Professional Network
• Build Your Knowledge Base
• Expand Your Resources
• Learning in a New Space
• Break Out of Your Comfort Zone
• New Tips & Tactics
• Top Industries Representation
• Abstracts will be published in the webinar souvenir and respective International journals
• Each Abstract will receive unique (DOI) Number provided by Cross Ref
• Website visibility to more than 35K visitors in less than 6 months
• Laudable talks by the top-notch of the Global Scientific Community
• The Serendipity of the Random Workshop
• Will be felicitated with International Organizing Committee Member (IOCM)
• Remarkable Awards and Global Recognition to meritorious Researchers